- Report
- August 2025
- 198 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- February 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- September 2025
- 602 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- January 2025
- 125 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- August 2025
- 150 Pages
Global
From €2963EUR$3,358USD£2,562GBP
€3485EUR$3,950USD£3,014GBP
- Report
- July 2025
- 350 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- August 2025
- 121 Pages
United States
From €2646EUR$2,999USD£2,289GBP
- Report
- February 2025
- 146 Pages
Middle East
From €2646EUR$2,999USD£2,289GBP
- Report
- July 2025
- 250 Pages
Africa, Middle East
From €3414EUR$3,869USD£2,953GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3414EUR$3,869USD£2,953GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3414EUR$3,869USD£2,953GBP
- Report
- July 2025
- 250 Pages
Europe
From €3414EUR$3,869USD£2,953GBP
- Report
- July 2025
- 250 Pages
North America
From €3414EUR$3,869USD£2,953GBP
- Report
- January 2025
- 180 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- August 2025
- 183 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 198 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 198 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 198 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- March 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- February 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP

The Generic Injectable market is a segment of the drug delivery industry that focuses on the production and distribution of generic injectable drugs. These drugs are typically administered via injection and are used to treat a variety of medical conditions. Generic injectables are typically cheaper than their branded counterparts, making them a popular choice for patients and healthcare providers alike.
Generic injectables are typically produced in bulk and then packaged and distributed to pharmacies and hospitals. The production process involves the use of sterile manufacturing techniques and quality control measures to ensure the safety and efficacy of the drugs.
Generic injectables are an important part of the drug delivery industry, as they provide an affordable and effective way to treat a variety of medical conditions.
Some companies in the Generic Injectable market include Hospira, Mylan, Teva Pharmaceuticals, Sandoz, and Fresenius Kabi. Show Less Read more